Arthritis
ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress
Published in Lab Business Week, June 21st, 2009
Roche announced that oral and poster presentations highlighting results from the extensive multi-national ACTEMRA(R) (tocilizumab) clinical development program will be presented at the 10th Annual Congress of the European League Against Rheumatism (EULAR), which will take place June 10-13, 2009, in Copenhagen, Denmark. The studies evaluate ACTEMRA, a novel treatment targeting interleukin-6 (IL-6) receptors, in patients with moderately to severely active RA. Select Platform Presentations/Poster Sessions -- "Tocilizumab Inhibits Structural Joint Damage, Improves Physical
Function, and Increases DAS28 Remission Rates in RA Patients Who
Respond...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2009-06-21)
More Articles from Lab Business Week
- Applied Physics
Johns Hopkins University Applied Physics Lab Group Joins OrthoCare Innovations - Asymchem Laboratories, Inc.
Asymchem Announces sFDA Certification for Drug Product Manufacturing - BASF
Argonne's Lithium-Ion Battery Technology to be Commercialized by BASF - Biotechnology Business
Microsoft Signs Agreement With Merck & Co. Inc. to Acquire Assets of Rosetta Biosoftware, Strengthening Position in Life Sciences Industry - Breast Cancer
Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting - Bruker Daltonics
Bruker Daltonics Announces Schering-Plough’s Selection of the New solariX FTMS for Structure Characterization and Impurity Testing - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
